Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

FY 2025/26 organic growth was 6% and EBIT growth1 in constant currencies was 4%. Reported revenue in DKK grew 4%, reflecting 2%-points negative impact from currencies. Organic growth rates by...

1 October 2025 - 30 September 2026 Coloplast delivered 5% organic growth in Q4, driven by continued strength in Chronic Care and Interventional Urology. EBIT growth1 in constant currencies was 0% and...